Beyond its involvement in cancer, aberrant expression of TFPI2 has been observed in a range of pathological conditions, including diabetes [10,24,34], atherosclerosis [35,36,37], and pregnancy-induced hypertension [23,38,39,40,41,42]. Here, TFPI2 is linked to cancer.